Quantitative Anti-HBc in Liver Pathological States in Patients with Chronic Hepatitis B Virus Infection

Figure 2

ROC curves of anti-HBc serum HBsAg and HBV DNA for predicting pathological grades ≥G2 (a, b), ≥G3 (c, d) and stages ≥S2 (e, f), =S4 (g, h) of HBeAg-positive (a, c, e, g) and HBeAg-negative (b, d, f, h) patients.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)